Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents

A method of reducing astringency comprising contacting the oral surface with an oral composition comprising an active ingredient comprising a zinc citrate agent and a potassium salt.

A method of reducing formation of plaque or tartar, caries or malodor comprising contacting the oral surface with an oral composition comprising an active ingredient comprising a zinc citrate agent and a potassium salt.

A method of treating inflammation in an oral tissue comprising:

• contacting the inflamed oral tissue with an oral composition comprising an active ingredient comprising a zinc citrate agent and a tocopherol agent.

An anti-plaque and desensitizing oral composition comprising:

• an active ingredient comprising a zinc citrate agent and a potassium citrate agent;
• and
• a copolymer of maleic anhydride and polyvinyl methyl ether and a polyphosphate.

An oral composition comprising:

• an oral care active ingredient comprising a zinc citrate agent and a tocopherol agent, wherein the tocopherol agent comprises at least one compound chosen from tocol (2-methyl-2-(4,8,12-trimethyltridecyl)-6-chromanol), α-tocopherol ((+)-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol), β-tocopherol ((+)-2,5,8-trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol), γ-tocopherol ((+)-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol), δ-tocopherol ((+)-8-methyl-2-(4,8,12-trimethyltridecyl)-6-chromanol), α-tocotrienol (2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-6-chromanol), β-tocotrienol (2,5,8-trimethyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-6-chromanol) or derivatives or mixtures thereof.

An oral composition comprising a zinc salt, a linear polyphosphate salt having an average chain length of 3 or less, and at least one of a potassium salt or a vitamin.